VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

Cerus Executive Compensation (FY25)

CERS · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
William Greenman
Latest say-on-pay support
=
June 2, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Cerus

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$500 for the Executive Compensation Report. Both reports for $900.
18 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
312 figures on this page: 301 cited to the filing that reported them, 11 calculated from figures it prints. See the citations

More on Cerus

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — William Greenman: $2,975,617 → $3,794,657 (27.5% higher)
Say-on-pay support: 91.8% → 91.7% (0.1 points lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Cerus' chief executive and what were they paid?
William Greenman was paid $3,794,657 in total compensation as President and Chief Executive Officer for fiscal 2025. Compared with the $2,975,617 reported for fiscal 2024, Greenman's total was 27.5% higher.
What was Cerus' say-on-pay result?
The say-on-pay proposal drew 91.7% of votes cast for or against in favor at the meeting held June 2, 2026 for fiscal 2025.
Which companies are in Cerus' peer group?
Companies named in the disclosed peer group include Akebia Therapeutics, AngioDynamics, Inc., Anika Therapeutics, Ardelyx, Inc. and BioLife Solutions, Inc., among others.
What is Cerus' chief executive pay ratio?
The company reported a chief executive pay ratio of 17.5:1 for fiscal 2025, against median employee compensation of $216,284.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Greenman
President and Chief Executive Officer
◇—◇◇◇—◇◇
Vivek Jayaraman
Chief Operating Officer
◇—◇◇◇—◇◇
Kevin Green
Vice President, Finance and Chief Financial Officer
◇—◇◇◇—◇◇
Richard Benjamin
Chief Medical Officer
◇—◇◇◇—◇◇
Chrystal Jensen
Chief Legal Officer and General Counsel
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Greenman
President and Chief Executive Officer
◇—◇—◇—◇◇
Vivek Jayaraman
Chief Operating Officer
◇—◇—◇—◇◇
Kevin Green
Chief Financial Officer
◇—◇—◇—◇◇
Richard Benjamin
Chief Medical Officer
◇—◇—◇—◇◇
Chrystal Jensen
Chief Legal Officer, General Counsel and Secretary
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Greenman
President and Chief Executive Officer
◇◇◇———◇◇
Vivek Jayaraman
Chief Operating Officer
◇◇◇———◇◇
Kevin Green
Chief Financial Officer
◇◇◇———◇◇
Richard Benjamin
Chief Medical Officer
◇◇◇———◇◇
Chrystal Jensen
Chief Legal Officer, General Counsel and Secretary
◇◇◇———◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Greenman
President and Chief Executive Officer
◇—◇—◇—◇◇
Vivek Jayaraman
Chief Operating Officer
◇—◇—◇—◇◇
Kevin Green
Chief Financial Officer
◇—◇—◇—◇◇
Chrystal Jensen
Chief Legal Officer, General Counsel and Secretary
◇—◇—◇—◇◇
Richard Benjamin
Chief Medical Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Chrystal JensenRSU◇——◇——◇
Chrystal JensenRSU◇——◇——◇
Kevin D. GreenRSU◇——◇——◇
Kevin D. GreenRSU◇——◇——◇
Richard BenjaminRSU◇——◇——◇
Richard BenjaminRSU◇——◇——◇
Vivek JayaramanRSU◇——◇——◇
Vivek JayaramanRSU◇——◇——◇
William M. GreenmanRSU◇——◇——◇
William M. GreenmanRSU◇——◇——◇
Fiscal 2022 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
William GreenmanRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/28/2032
Vivek JayaramanRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/28/2032
Kevin GreenRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/28/2032
Chrystal JensenRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/28/2032
Richard BenjaminRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/28/2032
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Chrystal Jensen
Chief Legal Officer, General Counsel and Secretary · Terms as announced by the company
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Benefits continuation◇
Kevin Green
Chief Financial Officer · Terms as announced by the company
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Benefits continuation◇
Richard Benjamin
Chief Medical Officer · Terms as announced by the company
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Benefits continuation◇
Vivek Jayaraman
Chief Operating Officer · Employment agreement
Severance multiple◇
Severance base◇
Benefits continuation on change in control◇
Benefits continuation◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Frank Witney, Ph.D
◇◇————◇
Ann Lucena
◇◇————◇
Eric Bjerkholt
◇◇————◇
Timothy L. Moore
◇◇————◇
Jami Dover Nachtsheim
◇◇————◇
Hua Shan, M.D., Ph.D
◇◇————◇
Daniel N. Swisher Jr
◇◇————◇
Dean Gregory
◇—————◇
Gail Schulze
◇—————◇
William M. Greenman served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Akebia Therapeutics AKBA
  • AngioDynamics, Inc. ANGO
  • Anika Therapeutics ANIK
  • Ardelyx, Inc. ARDX
  • BioLife Solutions, Inc. BLFS
  • CareDX, Inc. CDNA
  • Codexis, Inc. CDXS
  • Collegium Pharmaceutical, Inc. COLL
  • Dynavax Technologies Corp DVAX
  • Heron Therapeutics, Inc. HRTX
  • Innoviva, Inc. INVA
  • Karyopharm Therapeutics Inc. KPTI
  • MacroGenics, Inc. MGNX
  • MannKind Corporation MNKD
  • Mirum Pharmaceuticals, Inc. MIRM
  • OmniAb, Inc. OABI
  • OraSure Technologies, Inc. OSUR
  • Rigel Pharmaceuticals, Inc. RIGL
  • Travere Therapeutics, Inc. TVTX
  • Vanda Pharmaceuticals, Inc. VNDA

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 2, 2026=◇◇◇
2024June 3, 2025=◇◇◇
2023June 5, 2024=◇◇◇
2022June 7, 2023=◇◇◇
2021June 1, 2022=◇◇◇
2020June 2, 2021=◇◇◇
2019June 3, 2020=◇◇◇
2018June 5, 2019=◇◇◇
2017June 6, 2018=◇◇◇
2016June 7, 2017=◇◇◇
2015June 8, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- William Greenman (President and Chief Executive Officer), FY2025 total compensation $3,794,657 (base salary $793,750) [exec_comp, SEC accession 0001020214-26-000011, filed 2026-04-22]

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Tell me when Cerus files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Cerus disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Cerus sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Cerus' disclosed peer group is defensible, who names Cerus back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
312 figures on this page: 301 cited to the filing that reported them, 11 calculated from figures it prints.
301 cited to the filing
11 calculated from the filing

Documents cited

  1. 0001193125-26-255488
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001020214-26-000011
    CEO PAY RATIO · DIRECTOR COMPENSATION · GRANTS OF PLAN-BASED AWARDS IN FISCAL 2025 · OUTSTANDING EQUITY AWARDS AT 2025 FISCAL YEAR-END · and 1 more section
  3. 0001020214-26-000007
    Exhibit
  4. 0001193125-26-108629
    EX-10.1
  5. 0000950170-25-083561
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000950170-25-057130
    SUMMARY COMPENSATION TABLE · Summary Compensation Table
  7. 0000950170-24-071855
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000950170-24-048801
    SUMMARY COMPENSATION TABLE · Summary Compensation Table
  9. 0000950170-23-027377
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0000950170-23-015609
    Summary Compensation Table
  11. 0001193125-22-166216
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0001193125-21-184290
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0001193125-20-163494
    Item 5.07 Submission of Matters to a Vote of Security Holders
  14. 0001193125-19-167242
    Item 5.07 Submission of Matters to a Vote of Security Holders
  15. 0001193125-18-186770
    Item 5.07 Submission of Matters to a Vote of Security Holders
  16. 0001193125-17-198542
    Item 5.07 Submission of Matters to a Vote of Security Holders
  17. 0001193125-16-617872
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Cerus executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/CERS (accessed 2026).
Short form: data: Velarion

The paid brief for Cerus

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$500 for the Executive Compensation Report. Both reports for $900.
18 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Cerus and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

MedTech & Diagnostics rankings

Peers Cerus discloses

The companies named in CERS's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}